Brighton Jones’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-21,944
Closed -$18.1K – 1463
2026
Q2
$18.1K Buy
21,944
+10,465
+91% +$9.9K ﹤0.01% 1403
2026
Q1
$10.6K Buy
+11,479
New +$13.9K ﹤0.01% 1195

Other funds holding LAB

Brighton Jones's LAB Position: Q3 2026 in Review

Brighton Jones sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 21,944 shares — an estimated $18.1K sold.

Brighton Jones first reported a position in LAB in Q1 2026 and held it in 2 quarters. The position peaked at $18.1K in Q2 2026. 79 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Brighton Jones reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 21,944 Standard BioTools shares in Q3 2026, an estimated $18.1K.
  • Brighton Jones first reported a position in Standard BioTools in Q1 2026 and held it in 2 quarters.
  • Brighton Jones's Standard BioTools position peaked at $18.1K in Q2 2026.
  • 79 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.